Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis

References

• Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27: 264–72
   PubMed Web of Science ®Google Scholar
• Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802–10
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Practice and Research Clinical Gastroenterology 2004; 18: 353–72
   PubMed Web of Science ®Google Scholar
• Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003; 38: 1210–18
   PubMed Web of Science ®Google Scholar
• Gines P, Guevara M, Perez-Villa F. Management of hepatorenal syndrome: another piece of the puzzle. Hepatology 2004; 40: 16–18
   PubMed Web of Science ®Google Scholar
• Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology 2002; 122: 1658–76
   PubMed Web of Science ®Google Scholar
• Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32 Suppl 1: 157–70
   Web of Science ®Google Scholar
• Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841–56
   PubMed Web of Science ®Google Scholar
• Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology 2001; 33: 28–31
   PubMed Web of Science ®Google Scholar
• Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002–10
   PubMed Web of Science ®Google Scholar
• Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386–400
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634–41
   PubMed Web of Science ®Google Scholar
• Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25: 135–44
   PubMed Web of Science ®Google Scholar
• Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342: 1701–7
   PubMed Web of Science ®Google Scholar
• Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839–47
   PubMed Web of Science ®Google Scholar
• Salerno F, Merli M, Riggio O, Cazzaniga M, Valeriano V, Pozzi M, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40: 629–35
   PubMed Web of Science ®Google Scholar
• Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126: 469–75
   PubMed Web of Science ®Google Scholar
• Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142–53
   PubMed Web of Science ®Google Scholar
• Pardo A, Bartoli R, Lorenzo-Zuniga V, Planas R, Vinado B, Riba J, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858–63
   PubMed Web of Science ®Google Scholar
• Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999; 117: 414–19
   PubMed Web of Science ®Google Scholar
• Castellote J, Lopez C, Gornals J, Tremosa G, Farina ER, Baliellas C, et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 2003; 37: 893–6
   PubMed Web of Science ®Google Scholar
• Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403–9
   PubMed Web of Science ®Google Scholar
• Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000; 33: 43–8
   PubMed Web of Science ®Google Scholar
• Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004; 40: 55–64
   PubMed Web of Science ®Google Scholar
• Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140–8
   PubMed Web of Science ®Google Scholar
• Fernandez J, Ruiz del Arbol L, Serradila R, Gomez C, Guarner C, Durandez R, et al. Randomized, multicenter, controlled trial comparing oral norfloxacin vs intravenous ceftriaxone in the prevention of bacterial infections in cirrhotics with severe liver failure and gastrointestinal bleeding. J Hepatol 2005; 42[S2]: 4
   Web of Science ®Google Scholar
• Liu Q, Ping Duan Z, Kang Ha D, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441–9
   PubMed Web of Science ®Google Scholar